Lotte Biologics CEO James Park expressed concerns that orders may shift away from China, potentially impacting the company's business. This statement reflects a cautious outlook on the market, particularly in the context of the ongoing geopolitical tensions between the US and China. The CEO's comments may influence investor sentiment towards the biotech industry.